EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes

Fan Zhang, Shu-Sen Wang

Translational Breast Cancer Research · 2024-01 · 5 · 2-2

DOI: 10.21037/tbcr-23-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Breast Cancer Research, 2024-01. Verfasst von Fan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerimmune checkpoint inhibitors (ICIs)immunotherapypembrolizumab

Autor:innen und Institutionen

  • Department of Medical Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Zitieren

APA

Zhang, F., & Wang, S. S. (2024). Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes. Translational Breast Cancer Research, 5, 2-2. https://doi.org/10.21037/tbcr-23-23

Vancouver

Zhang F, Wang SS. Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes. Translational Breast Cancer Research. 2024;5:2-2. doi:10.21037/tbcr-23-23

BibTeX
@article{Zhang2024,
  author = {Zhang, Fan and Wang, Shu-Sen},
  title = {Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes},
  journal = {Translational Breast Cancer Research},
  year = {2024},
  volume = {5},
  pages = {2--2},
  doi = {10.21037/tbcr-23-23}
}
Kostenlos starten →